$LNTH News

Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH)

Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease

FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics

Lantheus Holdings Announces FDA Approval Of TAUKLARIFY, Radiodiagnostic Agent Indicated For PET Of Brain In Adults For Alzheimer’s Disease

Lantheus Holdings: Why I Am Exiting Before The Merger Closes

Lantheus (NASDAQ:LNTH) Reports Upbeat Q2 CY2026

Lantheus Reports Second Quarter 2026 Financial Results

Lantheus Holdings Q2 Adj. EPS $1.55 Beats $1.30 Estimate, Sales $388.200M Beat $362.416M Estimate

Truist Securities Downgrades Lantheus Holdings to Hold, Lowers Price Target to $102.5

Lantheus (LNTH) Agrees To Join Curium In Radiopharmaceuticals Deal

Lantheus Strikes Up to $8 Billion Go-Private Deal With Curium

TD Cowen Downgrades Lantheus Holdings to Hold, Lowers Price Target to $102.5

Analyst Calls Curium's $8 Billion Lantheus Buyout An 'Excellent Outcome' For Shareholders

Curium Announces Definitive Agreement to Merge with Lantheus

Mizuho Maintains Outperform on Lantheus Holdings, Lowers Price Target to $115

LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value

Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time

Lantheus Holdings (NASDAQ:LNTH) Is a High-Quality Technical Breakout Setup

Truist Securities Maintains Buy on Lantheus Holdings, Raises Price Target to $125

Mizuho Maintains Market Outperform on Lantheus Holdings, Raises Price Target to $120